Evaluating and Managing Osteoporosis in Men

Nurse Practitioner

Volumn 26, Issue 5, 2001, Pages

  Lawson, Marjorie Thomas ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; CLASSIFICATION; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT EDUCATION; REVIEW; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OSTEOPOROSIS; PATIENT EDUCATION; RISK FACTORS; SEX FACTORS;

EID: 0035350903     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/00006205-200105000-00004     Document Type: Article

References (64)

1. Consensus Development Statement: Who are candidates for prevention and treatment of osteoporosis? Osteoporos Int 1997;7:1-6.
2. Ray NF, Chan JK, Thamer M, et al.: Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:24-35.
3. Schneider EI, Guralnik JM: The aging of America: Impact on health care costs. JAMA 1990;263:335-40.
4. Siddiqui NA, Shetty KR, Duthid EH: Osteoporosis in older men: Discovering when and how to treat it. Geriatrics 1999;54(9):20-37.
5. National Osteoporosis Foundation: Osteoporosis Clinical Updates 1999;2(1):1-4.
6. Kanis JA, Pitt FA: Epidemoloty of osteoporosis. Bone 1992;13:S7-S15.
7. Orwoll ES, Klein, RF: Osteoporosis in men. Endocr Rev 1995;16:87-116.
8. Cooper C, Campion G, Melton LJ: Hip fractures in the elderly: A worldwide projection. Osteoporos Int 1992;2:285-89.
9. Seeman E: The dilemma of osteoporosis in men. Am J Med 1995;98(suppl 2A):76S-88S.
10. Cooper C, Atkinson EJ, O'Fallon WM, et al.: Incidence of clinically diagnosed veterbral fractures: A population-based study in Rochester Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-27.
11. Johansson C, Mellstrom D, Rosengren K, et al.: A community-based population study of vertebral fractures in 85 year-old men and women. Age Aging 1994;23:388-92.
12. McCance, KL, Huether, SE: Pathophysiology: The biologic basis for disease in adults and children. New York, N.Y.: Mosby, 1998:1445-49.
13. Ebling PR: Osteoporosis in men: New insights into aetology, pathogenesis, prevention, and management. Drugs Aging 1998;6(12):421-34.
14. Seeman E: Do men suffer with osteoporosis? Aust Fam Physician 1997;26(2):135-43.
15. Tobin JD, Fox KM, Cejku ML, et al.: Bone density changes in normal men: A 4-19 year old longitudinal study. J Bone Miner Res 1993;8(supp 14):S142.
16. Anderson FH: Osteoporosis in men. Int J Clin Prac 1998;52(3):176-80.
17. Cohen-Solal ME, Baudoin C, Omouri M, et al.: Bone mass in middle-aged osteoporotic men and their relatives: Familial effect. J Bone Miner Res 1998;13:1909-14.
18. Riggs BL, Melton LJ: Medical progress: Involutional osteoporosis. N Engl J Med 1986;314:1676-86.
19. Peris P, Guanabens N, Monegal A, et al.: Etiology and presenting symptoms in male osteoporosis. Br J Rheumatol 1995;34:936-41.
20. Scane AC, Sutcliffe AM, Francis, RM: Osteoporosis in men. Baillieres Clin Rheumatol 1993;7:589-601.
21. Wood RJ, Fleet JC: The genetics of osteoporosis: Vitamin D receptor polymorphisms. Annu Rev Nutr 1998;18:233-58.
22. Niewoehner CB: Osteoporosis in men: Is it more common than we think? Postgrad Med 1993;83(8):63-70.
23. Vermeulen A: Clinical review 24: Androgens in the aging male. J Clin Endrocrinol Metab 1991;73(2):221-24.
24. Jackson JA, Riggs MW, Spoekerman AM: Testosterone deficiency as a risk factor for hip fractures in men: A case-control study. Am J Med Sci 1992;304(1):4-8.
25. Forsen L, Bjartveir K, Bjorndal A, et al.: Ex-smokers and risk of hip fracture. Am J Public Health 1998;88(10):1481-83.
26. Forsen L, Bjorndal A, Bjartveir K, et al.: Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fractures. J Bone Miner Res 1994;9(11):1671-78.
27. Law MR, Hacksaw AK: A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect. Br Med J 1997;315:841-46.
28. Spencer H, Rubio N, Rubio E, et al.: Chronic alcoholism. Frequently overlooked cause of osteoporosis in men. Am J Med 1986;80(3):393-97
29. Chappard D, Plantard B, Petitjean M, et al.: Alcoholic cirrhosis and osteoporosis in men: A light and scanning electron microscopy study. J Stud Alcohol 1991;52(3):269-74.
30. Klein RF: Alcohol-induced bone disease: Impact of ethanol on osteoblast proliferation. Alcohol Clin Exp Res 1997;21(3):392-99.
31. Avery DH, Overall JE, Calil HM, et al.: Plasma calcium and phosphate during alcohol intoxication: Alcoholic versus nonalcoholics. J Stud Alcohol 1983;44:205-14.
32. Spencer H, Kraner L, Norris C, et al.: Effect of small doses of aluminum-containing antacids on calcium and phosphorus metabolism. Am J Clin Nutr 1982;36:32-40.
33. Orwell ES, Bliziotes M: Heterogeneity in osteoporosis: Men versus women. Rheum Dis Clin North Am 1994;20(3):671-89.
34. Bonner, F: Calcium and osteoporosis. Am J Clin Nutr 1994;60:831-36.
35. Nordin BE: Calcium and osteoporosis. J Nutr 1997;13(7/8):664-86.
36. Looker AC, Haris TB, Madans JH, et al.: Dietary calcium and hip fractures: The NHANES I epidemiologic follow-up study. Osteoporos Int 1993;3:177-84.
37. Paganini-Hill A, Chao A, Ross RK: Exercise and other factors in the prevention of hip fracture: The leisure world study. Epidemiology 1991;2:16-25.
38. Nguyen T, Sambrook P, Kelly P, et al.: Prediction of osteoporotic fractures by postural instability and bone density. Bone Miner 1992;307:1111-15.
39. National Institutes of Health Consensus Development Panel: Optimal calcium intake. JAMA 1994;272:1942-48.
40. Kerstetter T, Allen L: Dietary protein increases urinary calcium. J Nutr 1990;120:134-36.
41. Nordin BEC, Need AG, Morris HA, et al.: The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr 1993;123:1615-22.
42. Devine A, Criddle RA, Dick IM, et al.: A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr 1995;62:740-45.
43. Dawson-Hughes B, Harris SS: Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-61.
44. Szulc P, Arlot M, Chapuy MC, et al.: Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994;9:1591-95.
45. Orwoll ES: Osteoporosis in men. Endrocrinol Metab Clin North Am 1998;27(2):349-67.
46. Ybarra J, Ade R, Romeo H: Osteoporosis in men: A review. Nurs Clin North Am 1996;31(4):805-13.
47. Bardin CW, Swerdloff RS, Santen RJ: Androgens: Risks and benefits. J Clin Endocrinol Metab 1991;74:4-7.
48. Francis RM, Peacock M, Marshall DH: Spinal osteoporosis in men. Bone Miner 1989;5:347-57.
49. Seeman E, Melton LJ, O'Fallon WM, et al.: Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977-83.
50. Eastell R, Boyle IT, Compston J, et al.: Management of male osteoporosis: Report of the UK consensus group. Q J Med 1998;91:71-92.
51. Ledford, D, Apter, A, Brenner AM, et al.: Osteoporosis in the corticosteriod-treated patient with asthma. J Allergy Clin Immunol 1998;102(3):353-62.
52. Ebling, PR, Erbas, B, Hopper, JL, et al.: Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res 1998;13(8):1283-89.
53. Wisniewski AF, Lewis SA, Green DJ, et al.: Cross sectional investigation of the effects of inhaled corticosteriods on bone density and bone metabolism in patients with asthma. Thorax 1997;52:853-60.
54. Rodino MA, Shane E: Osteoporosis after organ transplantation. Am J Med 1998;104:459-69.
55. Aris RM, Renner JB, Winders AD, et al.: Increased rates of fractures and kyphosis: Sequellae of living into adulthood with cystic fibrosis. Ann Intern Med 1998;128:186-93.
56. World Health Organization: Assessment of fracture and its application to screening for postmenopausal osteoporosis. Geneva, Switzerland: WHO Technical Report Series 834, 1994.
57. Cavalieri TA: Management of osteoporosis in the new millennium. J Am Osteopath Assoc 2000 Jan;100(suppl 1):S16-S20.
58. Harvards Men's Health Watch: Osteoporosis in men. Palm Coast, Fla.: Harvard Medical School Health Publications Group, 1999;(9).
59. Orwell E, Ettinger M, Weiss S, et al.: Alendronate for the treatment of osteoporosis in men. N Engl J Med, 2000;343:604-10.
60. Adachi JD, Olszynski WP, Hanley DA, et al.: Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum 2000;29(4):228-51.
61. Pitt P, Li F, Todd P, et al.: A double-blind placebo-controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment:. Thorax 1998;53:351-56.
62. Saag KG, Emkey R, Schnitzer TJ, et al.: Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998;339:292-99.
63. Stephan JJ, Lachman M: Castrated men with bone loss: Effect of calcitonin treatment on biochemical indicies of bone remodeling. J Clin Endocrinol Metab 1989;69:523-27.
64. Reid IR, Wattie DJ, Evans MC, et al.: Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996;156:1173-77.